IONS CIK: 874015

Ionis Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.8
FY22:
−274
FY23:
−308
FY24:
−501
FY25:
−269
Change from FY21 to FY25
millions USD
FY21:
195
FY22:
−263
FY23:
−214
FY24:
−134
FY25:
−278
Change from FY21 to FY25
millions USD
FY21:
246
FY22:
−55.3
FY23:
644
FY24:
478
FY25:
676
millions USD
FY21:
472
FY22:
−593
FY23:
123
FY24:
−157
FY25:
130
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.8
FY22:
−290
FY23:
−331
FY24:
−546
FY25:
−320

All amounts in millions USD Data source:SEC EDGAR